Company Filing History:
Years Active: 2010
Title: The Innovations of Yuri Zhivilo
Introduction
Yuri Zhivilo is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biomedical engineering, particularly in the development of devices for biological valves. His innovative approach has led to advancements that enhance the functionality and reliability of these critical medical components.
Latest Patents
Zhivilo holds a patent for a "Reinforcement device for a biological valve and reinforced biological valve." This invention includes an arrangement of supports designed to establish a double-trigone geometry in the valve, which is crucial for its performance. The device features a plurality of commissural supports that define the geometry of a commissural trigone, along with intercommissural supports that establish the geometry of an intercommissural trigone. The method for reinforcing a biological valve involves using both sets of supports, which are coupled to a base upon which the valve is mounted. This innovative design aims to improve the durability and effectiveness of biological valves in medical applications.
Career Highlights
Zhivilo's career is marked by his dedication to advancing medical technology. His work at Leman Cardiovascular SA has positioned him as a key player in the development of cardiovascular solutions. His patent reflects his commitment to improving patient outcomes through innovative engineering.
Collaborations
Zhivilo has collaborated with esteemed professionals in the field, including Norman Jaffe and Afksendiyos Kalangos. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Yuri Zhivilo's contributions to the field of biomedical engineering, particularly through his patented reinforcement device for biological valves, demonstrate his innovative spirit and commitment to improving medical technology. His work continues to influence the development of effective cardiovascular solutions.